Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Vertex ; 23(104): 255-9, 2012.
Artigo em Espanhol | MEDLINE | ID: mdl-23170296

RESUMO

In 1987, the revision of the DSM-III reintroduced the concept of paranoia under the name of delusional disorder. Most of the actual evidence about the pharmacological treatment of this disorder is derived from case series and case reports. Antipsychotics have been used for the treatment of delusional disorder since 1970s, with pimozide as a first line drug. The introduction of second generation antipsychotics changed the treatment of the disorder. In spite of the available information, delusional disorder remains to this day a controversial and complex disorder.


Assuntos
Esquizofrenia Paranoide/diagnóstico , Esquizofrenia Paranoide/tratamento farmacológico , Humanos
2.
Vertex ; 18(75): 335-43, 2007.
Artigo em Espanhol | MEDLINE | ID: mdl-18273418

RESUMO

OBJECTIVE: The objective of this study was to examine the prescribing practices of Argentinean psychiatrists in the treatment of major depression and to observe similarities and/or differences with some consensus or treatment guidelines. METHODOLOGY: Four hundred two psychiatrists were surveyed during a specialty meeting in October 2005. RESULTS: A total of 88.2 % of psychiatrists surveyed considered that every depressed patient must be treated with medication. The most prescribed antidepressants for outpatients were paroxetine, sertraline and fluoxetine. Venlafaxine was included for inpatients. The majority of psychiatrists indicated antidepressant therapy lasting from 12 to 24 months after remission of the first depressive episode. Antidepressant dosages remained unchanged during that period. A low percentage had used lithium or thyroid hormones as augmentation medications, the addition of other antidepressant being the most used augmentation strategy. The most prescribed antidepressant combination was dual antidepressants and SSRIs. Prescribing practices differed according to personal factors of the physicians. CONCLUSIONS: Discrepancies between clinical practice and treatment guidelines were observed. Further research over the underlying causes of these discrepancies and mechanisms to reduce them are necessary.


Assuntos
Antidepressivos/uso terapêutico , Transtorno Depressivo Maior/tratamento farmacológico , Uso de Medicamentos/estatística & dados numéricos , Serviços de Saúde Mental/normas , Padrões de Prática Médica/estatística & dados numéricos , Psiquiatria/normas , Argentina/epidemiologia , Transtorno Depressivo Maior/epidemiologia , Prescrições de Medicamentos/estatística & dados numéricos , Fidelidade a Diretrizes/estatística & dados numéricos , Pesquisas sobre Atenção à Saúde , Humanos , Guias de Prática Clínica como Assunto , Inquéritos e Questionários
3.
Vertex ; 16(59): 43-8, 2005.
Artigo em Espanhol | MEDLINE | ID: mdl-15785788

RESUMO

Psychotropic drugs affect the regulatory mechanisms of different neuroendocrine axis. This chapter reviews the interactions between psychotropic drugs and prolactin, the hypothalamic-pituitary-thyroid axis and the hypothalamic-pituitary-gonadal axis. Hyperprolactinemia can cause galactorrhea, amenorrhea, sexual disfunction, impaired spermatogenesis and increased risk for osteoporosis and fractures. Atypical antipsychotics cause less hyperprolactinemia than conventional antipsychotics. Lithium has important effects on thyroid function. During lithium treatment, affectively ill patients show, in varying degrees and combinations, reduced levels of thyroid hormones and clinical evidence of subclinical hypothyroidism, overt hypothyroidism and goiter. Recent literature reports suggest that valproic acid, may be associated with polycistic ovarian syndrome. Until additional data is available, women starting valproate therapy should be warned about the possibility of endocrinology side effects.


Assuntos
Doenças do Sistema Endócrino/induzido quimicamente , Psicotrópicos/efeitos adversos , Feminino , Humanos , Hiperprolactinemia/induzido quimicamente , Sistema Hipotálamo-Hipofisário/efeitos dos fármacos , Masculino , Ovário/efeitos dos fármacos
4.
Vertex rev. argent. psiquiatr ; 16(59): 43-8, 2005 Jan-Feb.
Artigo em Espanhol | LILACS-Express | BINACIS | ID: biblio-1176812

RESUMO

Psychotropic drugs affect the regulatory mechanisms of different neuroendocrine axis. This chapter reviews the interactions between psychotropic drugs and prolactin, the hypothalamic-pituitary-thyroid axis and the hypothalamic-pituitary-gonadal axis. Hyperprolactinemia can cause galactorrhea, amenorrhea, sexual disfunction, impaired spermatogenesis and increased risk for osteoporosis and fractures. Atypical antipsychotics cause less hyperprolactinemia than conventional antipsychotics. Lithium has important effects on thyroid function. During lithium treatment, affectively ill patients show, in varying degrees and combinations, reduced levels of thyroid hormones and clinical evidence of subclinical hypothyroidism, overt hypothyroidism and goiter. Recent literature reports suggest that valproic acid, may be associated with polycistic ovarian syndrome. Until additional data is available, women starting valproate therapy should be warned about the possibility of endocrinology side effects.

5.
Vertex ; 16(59): 43-8, 2005 Jan-Feb.
Artigo em Espanhol | BINACIS | ID: bin-38468

RESUMO

Psychotropic drugs affect the regulatory mechanisms of different neuroendocrine axis. This chapter reviews the interactions between psychotropic drugs and prolactin, the hypothalamic-pituitary-thyroid axis and the hypothalamic-pituitary-gonadal axis. Hyperprolactinemia can cause galactorrhea, amenorrhea, sexual disfunction, impaired spermatogenesis and increased risk for osteoporosis and fractures. Atypical antipsychotics cause less hyperprolactinemia than conventional antipsychotics. Lithium has important effects on thyroid function. During lithium treatment, affectively ill patients show, in varying degrees and combinations, reduced levels of thyroid hormones and clinical evidence of subclinical hypothyroidism, overt hypothyroidism and goiter. Recent literature reports suggest that valproic acid, may be associated with polycistic ovarian syndrome. Until additional data is available, women starting valproate therapy should be warned about the possibility of endocrinology side effects.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...